GGrantIndex
Sort

17,828 grants matching crispr

Rewiring of regulatory networks by endogenous retroviruses

$372,813
Edward Bo-Yi Chuong · University Of Colorado · R35 · FY2021 · GM

Rewiring of regulatory networks by endogenous retroviruses

$372,813
Edward Bo-Yi Chuong · University Of Colorado · R35 · FY2022 · GM

Rewiring of regulatory networks by endogenous retroviruses

$372,813
Edward Bo-Yi Chuong · University Of Colorado · R35 · FY2019 · GM

Rewiring of regulatory networks by endogenous retroviruses

$372,813
Edward Bo-Yi Chuong · University Of Colorado · R35 · FY2018 · GM

Rewiring of regulatory networks by endogenous retroviruses

$372,813
Edward Bo-Yi Chuong · University Of Colorado · R35 · FY2020 · GM

The immune regulation of macrophage antibody dependent cellular phagocytosis

$372,801
Adam David Hoppe · South Dakota State University · U01 · FY2024 · AI

Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells

$372,796
Yingxiao Wang · University Of California, San Diego · R33 · FY2019 · CA

CANCAN - SALK

$372,748
Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2024 · CA

In Vivo Gene Targeting to Treat Inherited Bone Disease

$372,650
David R Deyle · Mayo Clinic Rochester · R01 · FY2019 · AR

Elucidating the origins of cortical tuber cells using human brain organoid models of TSC

$372,546
Helen S. Bateup · University Of California Berkeley · R01 · FY2024 · NS

Optimizing Genome Engineering with Targetable Nucleases

$372,500
Dana Carroll · University Of Utah · R01 · FY2014 · GM

Optimizing Genome Engineering with Targetable Nucleases

$372,500
Dana Carroll · University Of Utah · R01 · FY2017 · GM

Optimizing Genome Engineering with Targetable Nucleases

$372,500
Dana Carroll · University Of Utah · R01 · FY2016 · GM

Optimizing Genome Engineering with Targetable Nucleases

$372,500
Dana Carroll · University Of Utah · R01 · FY2015 · GM

Projection-specific gene expression in resilience to chronic stress

$372,379
Alfred J Robison · Michigan State University · R01 · FY2020 · MH

Investigating novel synthetic lethal epigenetic interactions in Acute Myeloid Leukemia

$372,361
Junwei Shi · University Of Pennsylvania · R01 · FY2025 · CA

CRISPR logic circuits for safer and controllable gene therapies

$372,336
Samira Kiani · Arizona State University-Tempe Campus · R01 · FY2019 · EB

Understanding and exploiting the functional diversity of CRISPR-Cas immune systems

$372,305
Chase Lawrence Beisel · North Carolina State University Raleigh · R35 · FY2018 · GM

Multiplexed nanoparticle delivery to increase CRISPR/Cas gene editing for enhanced cancer therapy

$372,136
Daniel John Siegwart · Ut Southwestern Medical Center · R01 · FY2024 · CA

Defining the Critical Function and Regulation of NNMT in Breast Cancer Progression and Metastasis

$372,125
Binhua P Zhou · University Of Kentucky · R01 · FY2024 · CA

Development and Validation of a Transgenic Rabbit Model of Dravet Syndrome

$372,094
Lori L Isom · University Of Michigan At Ann Arbor · R61 · FY2023 · NS

Cellular and Molecular Role of CXCR4 signaling in Painful Diabetic Neuropathy

$372,090
Daniela M Menichella · Northwestern University At Chicago · R01 · FY2019 · NS

RUI: Early Endings - Characterizing the Role of Hrp1 in RNA Polymerase II Transcription Attenuation

$372,026
Jason N Kuehner · Emmanuel College · · FY2022 · BIO

Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers

$371,925
Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2018 · CA

Generating rapid antitumor immunity with lymphocyte-reprogramming nanocarriers

$371,925
Matthias Stephan · Fred Hutchinson Cancer Research Center · R01 · FY2017 · CA